Dr. Toni K. Choueiri discusses Risk Factors and a Model to Predict Toxicity-related Treatment Discontinuation in Patients with Metastatic Renal Cell Carcinoma (mRCC) Treated with Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy: Results from the International Metastatic RCC Database Consortium (IMDC)
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content